Optionality
constrained — VC- and grant-funded private company; no evidence of founder/board super-control or self-funding independence. Investor base (pi Ventures, Kae Capital, HealthQuad, British International Investment — a UK DFI) implies standard board/investor oversight; the most recent large capital event (Wellcome Trust grant) is restricted-use program funding, if anything narrowing near-term discretion further, not loosening it.
Sourced figures 2
- PR Newswire / TechCrunch via Google News Series A/B investor syndicate (pi Ventures, Kae Capital, HealthQuad, British International Investment)
- Health Tech World via Google News £5.3m Wellcome Trust award is a restricted research/scale-up grant, not general operating capital
the working
Threads 1
A claim is one metric we assert about a node — the value is the summary, this page is the receipt. Sourced from kestrel; supersedes-history not yet shown. Back to Wysa.
